|
 |
|
| |
|
 |
| |
| |
|
| |
|
| |
|
|
"Core cGTP requirements (1271.150(b)) are those requirements that directly relate to preventing the introduction, transmission, or spread of communicable disease by HCT/Ps." |
| |
| |
| |
|
 |
cGTP Cell Processing |
 |
| |
| Our Understanding |
The goal of every cell processing facility must be the production of safe, pure, and potent cells.
• Processing cellular based therapies under cGMP requires sound scientific methods which are current, validated, and documented.
• The manipulation of cells, even in seemingly non-complex processes requires facilities, environments and methods that prevent the introduction, transmission and spread of communicable disease. TotipotentSC has the experience to guide you with this regulatory requirement.
|
| |
 |
| |
| A Unique Solution |
TotipotentSC is compliance focused with patient safety serving as the base for all recommendations. We have experience optimizing, implementing, and validating leading stem cell harvest, cell processing/expansion, environmental control, and cryopreservation technologies to ensure that you reach your purity and stability goals required under cGMP/cGTP regulations. |
| |
| Cellular Processing Consultation
|
• Process mapping/optimization/scale-up
• Turn-key facility design and installation
• Quality system development/optimization
• Environmental control monitoring
• Validation guidance for equipment, manufacture, quality procedures and chain-of-custody
• Product testing
• Cryopreservation
• Implementation of tracking systems
• Receipt and distribution planning
|
|
| |
|
|